Home/Filings/4/0001437749-22-015538
4//SEC Filing

Senderowicz Adrian 4

Accession 0001437749-22-015538

CIK 0001401667other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 9:55 PM ET

Size

4.9 KB

Accession

0001437749-22-015538

Insider Transaction Report

Form 4
Period: 2022-06-16
Transactions
  • Sale

    Common Stock

    2022-06-16$2.63/sh27,858$73,30327,000 total
Footnotes (2)
  • [F1]These shares were sold pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.554 to $2.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeother

Related Parties

1
  • filerCIK 0001616230

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 9:55 PM ET
Size
4.9 KB